Mingfeng Qiu
Impact in
-
- Traditional Chinese Medicine Analysis
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Metabolomics and Mass Spectrometry Studies 9
- RNA Interference and Gene Delivery 6
- Extracellular vesicles in disease 6
- Retinoids in leukemia and cellular processes 4
-
- Nanoplatforms for cancer theranostics 12
- Co-authors
- Jing Su (33 shared papers)Wei Jia (14 shared papers)Faisal Raza (21 shared papers)Guoxiang Xie (8 shared papers)Aihua Zhao (7 shared papers)Mingming Su (4 shared papers)Zhaohui Xu (3 shared papers)Zul Kamal (8 shared papers)
- Journals
- Pharmaceutics (4 papers)Biomaterials Science (4 papers)Evidence-based Complementary and Alternative Medicine (3 papers)Drug Delivery (3 papers)Journal of Ethnopharmacology (3 papers)
- Partner nations
- ChinaUnited StatesPakistan
In The Last Decade
Mingfeng Qiu
60 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 105
- Complementary and alternative medicine 229
- Biomaterials 263
- Pharmacology 151
- Pharmaceutical Science 109
- Biochemistry 63
Countries citing papers authored by Mingfeng Qiu
This map shows the geographic impact of Mingfeng Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingfeng Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingfeng Qiu more than expected).
Fields of papers citing papers by Mingfeng Qiu
This network shows the impact of papers produced by Mingfeng Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingfeng Qiu. The network helps show where Mingfeng Qiu may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingfeng Qiu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 140 | |
| 2 | 2009 | 112 | |
| 3 | 2016 | 111 | |
| 4 | 2011 | 83 | |
| 5 | 2006 | 73 | |
| 6 | 2007 | 67 | |
| 7 | 2021 | 56 | |
| 8 | 2014 | 49 | |
| 9 | 2021 | 46 | |
| 10 | 2012 | 44 | |
| 11 | 2019 | 42 | |
| 12 | 2019 | 40 | |
| 13 | 2013 | 35 | |
| 14 | 2005 | 31 | |
| 15 | 2021 | 30 | |
| 16 | 2013 | 29 | |
| 17 | 2021 | 28 | |
| 18 | 2020 | 28 | |
| 19 | 2015 | 26 | |
| 20 | 2018 | 25 |
About Mingfeng Qiu
Mingfeng Qiu is a scholar working on Molecular Biology, Biomedical Engineering, Biomaterials, Physiology and Pharmacology, having authored 60 papers that have together received 1.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (12 papers), Nanoplatforms for cancer theranostics (12 papers), Metabolomics and Mass Spectrometry Studies (9 papers), Erythrocyte Function and Pathophysiology (7 papers), RNA Interference and Gene Delivery (6 papers), Extracellular vesicles in disease (6 papers), Traditional Chinese Medicine Analysis (5 papers) and Retinoids in leukemia and cellular processes (4 papers). The work is most often cited by research in Complementary and alternative medicine (229 citations), Biomaterials (263 citations), Pharmacology (151 citations), Pharmaceutical Science (109 citations) and Biochemistry (63 citations). Mingfeng Qiu has collaborated with scholars based in China, United States and Pakistan. Frequent co-authors include Jing Su, Wei Jia, Faisal Raza, Guoxiang Xie, Aihua Zhao, Mingming Su, Zhaohui Xu, Zul Kamal, Yongyu Zhang and Aihua Zhao. Their work appears in journals such as Pharmaceutics, Biomaterials Science, Evidence-based Complementary and Alternative Medicine, Drug Delivery and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.